China
· Delayed Price · Currency is CNY BMC Medical Statistics
Total Valuation
BMC Medical has a market cap or net worth of CNY 7.39 billion. The enterprise value is 4.91 billion.
| Market Cap | 7.39B |
| Enterprise Value | 4.91B |
Important Dates
The next estimated earnings date is Thursday, August 28, 2025.
| Earnings Date | Aug 28, 2025 |
| Ex-Dividend Date | May 28, 2025 |
Share Statistics
BMC Medical has 88.91 million shares outstanding. The number of shares has decreased by -0.11% in one year.
| Current Share Class | 88.91M |
| Shares Outstanding | 88.91M |
| Shares Change (YoY) | -0.11% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 31.72% |
| Owned by Institutions (%) | 11.90% |
| Float | 32.27M |
Valuation Ratios
The trailing PE ratio is 41.85 and the forward PE ratio is 29.59.
| PE Ratio | 41.85 |
| Forward PE | 29.59 |
| PS Ratio | 8.06 |
| PB Ratio | 2.54 |
| P/TBV Ratio | 2.55 |
| P/FCF Ratio | 70.82 |
| P/OCF Ratio | 61.51 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 35.78, with an EV/FCF ratio of 47.04.
| EV / Earnings | 27.67 |
| EV / Sales | 5.36 |
| EV / EBITDA | 35.78 |
| EV / EBIT | 42.42 |
| EV / FCF | 47.04 |
Financial Position
The company has a current ratio of 6.60, with a Debt / Equity ratio of 0.11.
| Current Ratio | 6.60 |
| Quick Ratio | 6.37 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | 2.31 |
| Debt / FCF | 3.03 |
| Interest Coverage | 26.92 |
Financial Efficiency
Return on equity (ROE) is 6.30% and return on invested capital (ROIC) is 2.38%.
| Return on Equity (ROE) | 6.30% |
| Return on Assets (ROA) | 2.27% |
| Return on Invested Capital (ROIC) | 2.38% |
| Return on Capital Employed (ROCE) | 3.97% |
| Revenue Per Employee | 1.05M |
| Profits Per Employee | 202,511 |
| Employee Count | 876 |
| Asset Turnover | 0.29 |
| Inventory Turnover | 5.40 |
Taxes
In the past 12 months, BMC Medical has paid 20.20 million in taxes.
| Income Tax | 20.20M |
| Effective Tax Rate | 10.04% |
Stock Price Statistics
The stock price has increased by +40.73% in the last 52 weeks. The beta is 1.01, so BMC Medical's price volatility has been similar to the market average.
| Beta (5Y) | 1.01 |
| 52-Week Price Change | +40.73% |
| 50-Day Moving Average | 81.96 |
| 200-Day Moving Average | 71.04 |
| Relative Strength Index (RSI) | 52.79 |
| Average Volume (20 Days) | 1,202,144 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BMC Medical had revenue of CNY 916.68 million and earned 177.40 million in profits. Earnings per share was 1.99.
| Revenue | 916.68M |
| Gross Profit | 426.26M |
| Operating Income | 115.73M |
| Pretax Income | 201.17M |
| Net Income | 177.40M |
| EBITDA | 127.82M |
| EBIT | 115.73M |
| Earnings Per Share (EPS) | 1.99 |
Balance Sheet
The company has 2.81 billion in cash and 316.67 million in debt, giving a net cash position of 2.49 billion or 28.01 per share.
| Cash & Cash Equivalents | 2.81B |
| Total Debt | 316.67M |
| Net Cash | 2.49B |
| Net Cash Per Share | 28.01 |
| Equity (Book Value) | 2.91B |
| Book Value Per Share | 32.60 |
| Working Capital | 2.63B |
Cash Flow
In the last 12 months, operating cash flow was 120.16 million and capital expenditures -15.79 million, giving a free cash flow of 104.37 million.
| Operating Cash Flow | 120.16M |
| Capital Expenditures | -15.79M |
| Free Cash Flow | 104.37M |
| FCF Per Share | 1.17 |
Margins
Gross margin is 46.50%, with operating and profit margins of 12.62% and 19.35%.
| Gross Margin | 46.50% |
| Operating Margin | 12.62% |
| Pretax Margin | 21.95% |
| Profit Margin | 19.35% |
| EBITDA Margin | 13.94% |
| EBIT Margin | 12.62% |
| FCF Margin | 11.39% |
Dividends & Yields
This stock pays an annual dividend of 0.40, which amounts to a dividend yield of 0.47%.
| Dividend Per Share | 0.40 |
| Dividend Yield | 0.47% |
| Dividend Growth (YoY) | -60.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 37.79% |
| Buyback Yield | 0.11% |
| Shareholder Yield | 0.59% |
| Earnings Yield | 2.40% |
| FCF Yield | 1.41% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 29, 2024. It was a forward split with a ratio of 1.4.
| Last Split Date | May 29, 2024 |
| Split Type | Forward |
| Split Ratio | 1.4 |
Scores
BMC Medical has an Altman Z-Score of 9.12 and a Piotroski F-Score of 5.
| Altman Z-Score | 9.12 |
| Piotroski F-Score | 5 |